Elagin Vecheslav A 4
4 · MERIDIAN BIOSCIENCE INC · Filed Nov 13, 2017
Insider Transaction Report
Form 4
Elagin Vecheslav A
Sr VP, Research & Development
Transactions
- Award
Common Stock
2017-11-08+7,500→ 55,989 total - Award
Stock Options (Right to Buy)
2017-11-08+12,500→ 12,500 totalExercise: $14.65Exp: 2027-11-08→ Common Stock (12,500 underlying) - Disposition to Issuer
Common Stock
2017-11-09−10,000→ 45,989 total
Holdings
- 80(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest in full (100%) on November 15, 2021.
- [F2]These restricted stock units were awarded under the 2012 Stock Incentive Plan and were subject to attainment by the Company of a specified earnings target for fiscal 2017. As the Company did not reach the target, these restricted stock units have been cancelled.
- [F3]These options are granted awarded under the 2012 Stock Incentive Plan and vest in full (100%) on November 15, 2021.